Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?

ABSTRACT:

SUBMITTER: Mienko F 

PROVIDER: S-EPMC7333146 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature